Document is current
Any future updates will be listed below
-
Authors
van Dalen, Bas M.
Chin, Jie Fen
Motiram, Praveen A.
Hendrix, Anneke
Emans, Mireille E.
Brugts, Jasper J.
Westenbrink, B. Daan
de Boer, Rudolf A.
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 23 January 2025
First Online: 7 February 2025
Declarations
:
: The institution of Dr. De Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche; Dr. de Boer received travel support from Abbott, Cardior Pharmaceuticals GmbH, and NovoNordisk. Dr Brugts reports speaker engagements and/or advisory to Astra Zeneca, Abbott, Bayer, Boehringer Ingelheim, Novartis and Vifor outside the submitted work (3 year period). The institution of Dr. Van Dalen received research grants from Biotronik SE & Co. KG, Boehringer Ingelheim, Pfizer, Daiichi Sankyo, Sanofi and Novo Nordisk.
